Ex vivo virus infection of HDM-sensitized lung tissue proves inadequate anti-viral immune response in small airways

O. Danov (Hannover, Germany)

Source: International Congress 2017 – Animal models of asthma and allergies
Session: Animal models of asthma and allergies
Session type: Thematic Poster
Number: 1140
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Danov (Hannover, Germany). Ex vivo virus infection of HDM-sensitized lung tissue proves inadequate anti-viral immune response in small airways. 1140

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005


Interferon-dependant and immune cell-based mechanisms of antiviral resistance of the human lung vascular endothelium infected with rhinovirus HRV16
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021

Induction of innate immune response in fresh human lung tissue ex vivo following P. aeruginosa infection
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018


LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015

Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract
Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016
Year: 2017



Breathprints of model murine bacterial lung infections are linked with immune response
Source: Eur Respir J 2015; 45: 181-190
Year: 2015



HIV-1 infection impairs the bronchoalveolar immune response to mycobacteria
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Inflammatory exacerbation and inadequate interferone response to RV1b infection in HDM-sensitized lung tissue
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

The innate immune function of airway epithelial cells in inflammatory lung disease
Source: Eur Respir J 2015; 45: 1150-1162
Year: 2015



MAIT cells contribute to a protective antiviral innate response to influenza infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018




Accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006


Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
Source: Eur Respir Rev 2015; 24: 356-360
Year: 2015



How infections can modify lung immunity
Source: Eur Respir J 2001; 18: 442-443
Year: 2001


How infections can modify lung immunity
Source: Guideline 2001
Year: 2001

LSC 2010 Abstract: Deficient innate immune antiviral response to infection with rhinoviruses in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010

Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



From ineffective tumor immune response to immunomodulation in lung cancer
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017